Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Multiple Myeloma Program Treatment Team

  • Drs. Richardson and Laubach

    Our program encompasses physicians, clinicians and a large, international team of laboratory-based and clinical investigators who are striving to find more effective therapies. Physicians work closely with research scientists in a "bench-to-bedside" approach that identifies promising new treatments by rapidly translating laboratory discoveries into the clinical setting.

    Multiple Myeloma Program Leadership

    Kenneth C. Anderson, MD, Program Director
    Paul G. Richardson, MD, Clinical Program Leader and Director of Clinical Research
    Jacob Laubach, MD, MPP, Chief and Clinical Director
    Nikhil C. Munshi, MD, Director of Basic and Correlative Science